Preferentially Expressed Antigen In Melanoma (PRAME) Polyclonal Antibody CAU22004 from Biomatik

Description

Preferentially Expressed Antigen In Melanoma (Prame) Polyclonal Antibody is a Human (Homo sapiens) Polyclonal Antibody to Preferentially Expressed Antigen In Melanoma (PRAME). The Preferentially Expressed Antigen In Melanoma (Prame) Polyclonal Antibody has been validated for the following applications: WB, IHC, ICC, IP

Product Specs
ItemPreferentially Expressed Antigen In Melanoma (PRAME) Polyclonal Antibody
CompanyBiomatik
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberCAU22004
ClonalityPolyclonal
ReactivityHuman (Homo sapiens)
ApplicationsWB, IHC, ICC, IP
Quantity100ul
ImmunogenAsn416~Leu502
Brand/TrademarkBiomatik Corporation
PurityAntigen-specific affinity chromatography followed by Protein A affinity chromatography
Conjugate/TagUnconjugated. Conjugated antibodies are available (APC_Cy7, PE, APC, Cy3, Biotin, FITC and HRP), please inquire
HostRabbit
TargetPreferentially Expressed Antigen In Melanoma (PRAME)
NCBI Gene AliasesOIP-4, OIP4, CT130, MAPE
NCBI Full Gene NamePRAME nuclear receptor transcriptional regulator
ConcentrationLot specific. Please inquire or refer to the datasheet included in the product pouch
Storage2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles
Format0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol
Research AreaTumor Immunity
ValidationIHC Validated